The COVID-19 pandemic has shaken everyone around the world. There may not be any country or region that has been left untouched by this virus. The most concerning factor for everyone about the situation is that there is no dedicated vaccine for curing it. Therefore, people who are getting affected are either recovering on their own or are dying. To stop all this, several medical firms are working on developing a vaccine. One of those firms is from India, and it is Bharat Biotech. The company collaborated with the Indian Council of Medical Research (ICMR) to come up with the concept of COVAXIN.

Bharat Biotech’s name came in front, beating all other vaccine developers because COVAXIN has cleared the phase-1 tests and is ready to be moved in phase-2. This information was provided by Dr. Balram Bhargava during a press conference. He works at ICMR.

COVAXIN making it to phase-2, means the medicine has been proven safe for human consumption. The second phase is to analyze its efficiency to see how well it can cure the virus.

History Of Coronavirus

In early January, a new virus got generated from the Wuhan city of China. It then started spreading worldwide, and its adverse effects were seen in places like Italy in no time. People were getting affected at a high rate, and the hospitals were getting stuffed in these places. As soon as the other countries got warned, they declared lockdowns in their regions. It stopped the aggressive spread of the coronavirus. However, the virus still continues to affect people all around the world.

Coronavirus Vaccine

Ever since the virus was found in most countries in late February, the work on its vaccine began. Initially, experts tried to cure people with existing medicines. When that didn’t work, different medical firms from all over the world started building the vaccine from scratch. Several of those companies were from India. Now, the good news has come that the COVAXIN developed by Bharat Biotech has cleared the phase-1 of corona testing.

The Next Steps

After the phase-1 testing, Bharat Biotech has to make its vaccine go through the phase-2 tests. This consists of a mid-scale examination where a significant amount of people will be given this medicine. While phase-1 checked that the vaccine is safe for human consumption, phase-2 will test how well it works. The results will be analyzed based on different groups, divided according to their age, health, and other factors. A few safety factors will also be analyzed.

If the COVAXIN manages to clear the phase-2 testing, it will be sent into the third phase. It is the most advanced phase that would help authorities approve the vaccine.

Conclusion

People have been so scared of the coronavirus that every news related to its vaccine brings a sense of relief to them. All thanks to Bharat Biotech, which has developed this safe and efficient vaccine COVAXIN in India. Once the medicine gets through all the tests, we will see things getting back to normal soon.